ProfileGDS4132 / 202843_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 32% 26% 36% 30% 24% 31% 29% 43% 31% 32% 44% 45% 41% 48% 29% 40% 52% 32% 35% 45% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10179.858532
GSM201543Muscle PCOS pioglitazone 12153.133126
GSM201544Muscle PCOS pioglitazone 16194.810436
GSM201545Muscle PCOS pioglitazone 20181.251230
GSM201829Muscle PCOS pioglitazone 23160.285124
GSM201830Muscle PCOS pioglitazon 25179.750531
GSM201831Muscle PCOS pioglitazone 27168.274729
GSM201832Muscle PCOS pioglitazone 31109.83843
GSM201833Muscle PCOS pioglitazone 4171.789831
GSM201834Muscle PCOS pioglitazone 8176.071432
GSM201835Muscle PCOS after pioglitazone 102100.95944
GSM201836Muscle PCOS after pioglitazone 122108.49645
GSM201837Muscle PCOS after pioglitazone 16291.307841
GSM201838Muscle PCOS after pioglitazone 202115.84448
GSM201839Muscle PCOS after pioglitazone 23265.296829
GSM201840Muscle PCOS after pioglitazone 25299.55140
GSM201841Muscle PCOS after pioglitazone 272124.67452
GSM201842Muscle PCOS after pioglitazone 3264.37732
GSM201843Muscle PCOS after pioglitazone 4285.606935
GSM201844Muscle PCOS after pioglitazone 82114.85545